SGT-53 in Children With Recurrent or Progressive CNS Malignancies

Clinical trial NCT03554707 · WITHDRAWN

Trial details

NCT number: NCT03554707
Sponsor: SynerGene Therapeutics, Inc.
Status: WITHDRAWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Childhood CNS Tumor

Start date: 2022-06-01
Primary completion: 2022-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.